Diabetic Retinopathy: Current Understanding, Mechanisms, and Treatment Strategies
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: closed (30 April 2021) | Viewed by 2485
Special Issue Editor
Special Issue Information
Dear Colleagues,
As we are observing a dramatic increase in the number of persons affected by diabetes worldwide, diabetes-associated eye complications are rapidly emerging as a global health issue that may threaten patients’ visual acuity and visual function. Even though the treatment of diabetic retinopathy can reduce the risk of visual loss by 60%, diabetic retinopathy still remains the leading cause of blindness among working-age adults.
Therefore, the identification of mechanisms behind the pathophysiology and therapies of diabetic retinopathy is an area of significant research efforts, attracting scientists from a diverse range of fields, including neuroscience, pharmacology, and medicinal chemistry, among several others. This Special Collection is aimed at highlighting the importance of the discovery and mechanistic characterization of novel drug targets, signaling pathways, and mechanisms of action.
Potential papers to submit include, but are not limited to, laboratory and clinical studies on diabetes-associated ocular complications.
Prof. Giuseppe Querques
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- diabetic retinopathy
- pathogenesis
- therapeutic approaches
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
